James Hawkins - Feb 15, 2022 Form 4 Insider Report for IRADIMED CORP (IRMD)

Role
Director
Signature
/s/ James Hawkins
Stock symbol
IRMD
Transactions as of
Feb 15, 2022
Transactions value $
-$460,173
Form type
4
Date filed
2/17/2022, 04:05 PM
Previous filing
Dec 9, 2021
Next filing
Jul 8, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction IRMD Common Stock Award $14K +9.44K +43.93% $1.48 30.9K Feb 15, 2022 Direct F1
transaction IRMD Common Stock Sale -$474K -9.44K -30.52% $50.22 21.5K Feb 15, 2022 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction IRMD Stock Options (Right to Buy) Options Exercise $0 -9.44K -100% $0.00* 0 Feb 15, 2022 Common Stock 9.44K $1.48 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This option, representing a right to purchase a total of 140,000 shares, was granted on 12-31-2013 and vested over 4 years in equal annual installments commencing on the first anniversary of the grant date.
F2 This transaction was executed in multiple trades at prices ranging from $50.20 to $50.34. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.